Get Equity Tips
Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board
of Directors of the company will be held on February 17, 2016, inter
alia, to consider the Buyback of Equity Shares of the Company.
Stock commentary:
Dr Reddys Laboratories Ltd ended at Rs. 2886.85, down by Rs. 72.8 or 2.46% from its previous closing of Rs. 2959.65 on the BSE.
The scrip opened at Rs. 2920 and touched a high and low of Rs. 2935 and Rs. 2828 respectively. A total of 713535(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 49251.87 crore.
Stock commentary:
Dr Reddys Laboratories Ltd ended at Rs. 2886.85, down by Rs. 72.8 or 2.46% from its previous closing of Rs. 2959.65 on the BSE.
The scrip opened at Rs. 2920 and touched a high and low of Rs. 2935 and Rs. 2828 respectively. A total of 713535(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 49251.87 crore.
Dr Reddys Laboratories Ltd
BSE
2,950.90
64.05 (2.22%)
NSE
2,952.70
67.65 (2.34%)
The BSE group 'A' stock of face value Rs. 5 touched a 52 week high of
Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750 on 21-Jan-2016.
Last one week high and low of the scrip stood at Rs. 3123.3 and Rs.
2828 respectively.
The promoters holding in the company stood at 25.51 % while Institutions and Non-Institutions held 41.91 % and 14.35 % respectively. The stock traded above its 200 DMA.
Real-time market news- The 50 index NSE Nifty is trading at 8,103 up 15 points. For more information visit Epic Research.
ReplyDelete• Bharti Airtel close to buying Tikona's 4G spectrum, Overall value of the deal may be 1,500-1,700 cr.
ReplyDelete• Marico to acquire 45% equity stake in Zed Lifestyle.
CapitalStars